Early research (Phase 1)UnknownNCT03634982What this trial is testingDose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsWho this might be right forSolid Tumors Revolution Medicines, Inc. 133
Testing effectiveness (Phase 2)UnknownNCT02188550What this trial is testingSingle Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial CancerWho this might be right forOvarian CancerEndometrial Cancer Sinai Hospital of Baltimore 20
Testing effectiveness (Phase 2)Study completedNCT04332653What this trial is testingNT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsWho this might be right forAny Advanced Solid TumorsTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more NeoImmuneTech 215
Early research (Phase 1)Study completedNCT01237067What this trial is testingOlaparib in Combination With Carboplatin for Refractory or Recurrent Women s CancersWho this might be right forOvarian CancerBreast CancerPrimary Peritoneal Cancer+2 more National Cancer Institute (NCI) 77
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT01681368What this trial is testingBirinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal CancerWho this might be right forEpithelial Ovarian CancerPeritoneal NeoplasmsFallopian Tube Neoplasms National Cancer Institute (NCI) 11
Large-scale testing (Phase 3)Study completedNCT03534453What this trial is testingOlaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyWho this might be right forRelapsed Ovarian CancerFollowing Complete or Partial Response to Platinum Based ChemotherapyPlatinum Sensitive AstraZeneca 229
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370818What this trial is testingTo Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian CancerWho this might be right forOvarian Cancer Onconic Therapeutics Inc. 81
Early research (Phase 1)Study completedNCT02009631What this trial is testingEvaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid TumorsWho this might be right forBreast CancerOvarian CancerColon Cancer+3 more AbbVie 45
Testing effectiveness (Phase 2)Study completedNCT02383251What this trial is testingPaclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian CancerWho this might be right forOvarian Cancer ARCAGY/ GINECO GROUP 118
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06602063What this trial is testingSurgery for Relapsed Ovarian Cancer in PrecisionWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma Shanghai Gynecologic Oncology Group 33
Not applicableLooking for participantsNCT05366881What this trial is testingCfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseWho this might be right forBrain CancerBreast CancerBladder Cancer+17 more Adela, Inc 7,000
Testing effectiveness (Phase 2)WithdrawnNCT02836028What this trial is testingA Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal CancerWho this might be right forOvarian Cancer Pfizer
Testing effectiveness (Phase 2)UnknownNCT00551122What this trial is testingGemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell TumorsWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more University of Southampton 23
Testing effectiveness (Phase 2)Looking for participantsNCT04518501What this trial is testingFuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian CancerWho this might be right forEfficacy and Safety Xing Xie 50
Early research (Phase 1)Not Yet RecruitingNCT07674615What this trial is testingIMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancersPrimary+1 more Shanghai Gynecologic Oncology Group 19
Not applicableStudy completedNCT03505307What this trial is testingLynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation)Who this might be right forOvarian Cancer AstraZeneca 846
Early research (Phase 1)Study completedNCT00346385What this trial is testingBB-10901 in Treating Patients With Relapsed or Refractory Solid TumorsWho this might be right forOvarian CancerMerkel Cell CarcinomaSCLC ImmunoGen, Inc. 97